7V0 — Darwin AG Income Statement
0.000.00%
HealthcareAdventurousSmall Cap
- €82.20m
- €84.48m
- €18.17m
Annual income statement for Darwin AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|
Period Length: | 42 W | 12 M | 12 M |
Source: | ARS | ARS | ARS |
Standards: | GAS | GAS | GAS |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 111 | 210 | 18.2 |
Cost of Revenue | |||
Gross Profit | 55.2 | 120 | 6.03 |
Selling / General / Administrative Expenses | |||
Depreciation and Amortization | |||
Unusual Expense / Income | |||
Other Operating Expenses | |||
Total Operating Expenses | 81.4 | 151 | 26.7 |
Operating Profit | 29.5 | 59.2 | -8.56 |
Total Net Non Operating Interest Income / Expense | |||
Net Income Before Taxes | 29.5 | 59.7 | 3.02 |
Provision for Income Taxes | |||
Net Income After Taxes | 19.4 | 45.1 | 0.04 |
Net Income Before Extraordinary Items | |||
Net Income | 19.4 | 45.1 | 0.04 |
Adjustments to Net Income | |||
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | 19.4 | 45.1 | 0.04 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | 6.5 | 16.5 | 1.17 |
Dividends per Share |